For men, women aged older than 65 years, small-head cemented metal-on-polyethylene cost-effective
MONDAY, Dec. 10, 2018 (HealthDay News) — For older patients, small-head cemented metal-on-polyethylene implants are the cost-effective choice for total hip replacements, according to a study recently published in Value in Health.
Christopher G. Fawsitt, Ph.D., from the University of Bristol in the United Kingdom, and colleagues developed a Markov model to compare the cost-effectiveness of implants for total hip replacement among patients of different age and sex profiles. The authors estimated the probability that patients would require one or more revision surgeries from analyses of more than 1 million patients aged younger than 55, 55 to 64, 65 to 74, 75 to 84, and 85 years and older.
The researchers found that for men and women older than 65 years, small-head cemented metal-on-polyethylene implants were the most cost-effective; the findings were robust to sensitivity analyses. They noted that uncemented, hybrid, reverse hybrid, and other bearing surface combinations performed poorly because of higher implant costs and poorer revision rates. For men and women aged younger than 65 years, small-head cemented ceramic-on-polyethylene implants yielded the highest incremental net monetary benefit; however, these results were more uncertain and revision rates were not precise.
“Our study can influence clinical practice and commissioning of services,” the authors write. “We, however, highlight the need for rigorous randomized clinical trials with long-term follow-up before costly new implants are widely adopted in practice.”
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Early Complications Common in Older Kidney Transplant Recipients
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026
Frequent Cannabis Use Linked to Epilepsy Severity
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes